Genetics, Vol. 158, 627-634, June 2001, Copyright © 2001

Genetic Evidence Supports a Role for the Yeast CCR4-NOT Complex in Transcriptional Elongation

Clyde L. Denisa, Yueh-Chin Chianga, Yajun Cuia, and Junji Chena
a Department of Biochemistry and Molecular Biology, University of New Hampshire, Durham, New Hampshire 03824

Corresponding author: Clyde L. Denis, Department of Biochemistry and Molecular Biology, Rudman Hall, University of New Hampshire, Durham, NH 03824., cldenis{at}christa.unh.edu (E-mail)

Communicating editor: M. HAMPSEY


*  ABSTRACT
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

The CCR4-NOT complex is involved in the regulation of gene expression both positively and negatively. The repressive effects of the complex appear to result in part from restricting TBP access to noncanonical TATAA binding sites presumably through interaction with multiple TAF proteins. We provide here genetic evidence that the CCR4-NOT complex also plays a role in transcriptional elongation. First, defects in CCR4-NOT components as well as overexpression of the NOT4 gene elicited 6-azauracil (6AU) and mycophenolic acid sensitivities, hallmarks of transcriptional elongation defects. A number of other transcription initiation factors known to interact with the CCR4-NOT complex did not elicit these phenotypes nor did defects in factors that reduced mRNA degradation and hence the recycling of NTPs. Second, deletion of ccr4 resulted in severe synthetic effects with mutations or deletions in the known elongation factors RPB2, TFIIS, and SPT16. Third, the ccr4 deletion displayed allele-specific interactions with rpb1 alleles that are thought to be important in the control of elongation. Finally, we found that a ccr4 deletion as well as overexpression of the NOT1 gene specifically suppressed the cold-sensitive phenotype associated with the spt5-242 allele. The only other known suppressors of this spt5-242 allele are factors involved in slowing transcriptional elongation. These genetic results are consistent with the model that the CCR4-NOT complex, in addition to its known effects on initiation, plays a role in aiding the elongation process.


EUKARYOTIC gene expression is characterized by the interaction of a number of factors and large protein complexes, each of which may have multiple roles in the formation of mRNA. For example, TAFII proteins are components of both TFIID that is involved in transcription initiation and the SAGA complex that is proposed to affect chromatin accessibility (GRANT et al. 1997 Down; STERNER et al. 1999 Down). TFIID has also been shown to recruit a factor important for polyadenylation of mRNA (DANTONEL et al. 1997 Down), suggesting a role for TFIID in 3' end formation of mRNA. Individual subunits of TFIID have multiple functions. For instance, TAFII250 can acetylate and ubiquitinate histones as well as regulate TBP access to DNA (MIZZEN et al. 1996 Down; LIU et al. 1998A Down; PHAM and SAUER 2000 Down). The TFIIH complex, in addition to its known roles in initiation and in promoter clearance (KIM et al. 2000 Down), aids in DNA excision repair (DRAPKIN et al. 1994 Down). The carboxy-terminal domain (CTD) of RNA polymerase II enjoys multiple functions both in initiation and in postinitiation processes such as mRNA capping, splicing, and polyadenylation (MCCRACKEN et al. 1997 Down; HIROSE and MANLEY 1998 Down; HIROSE et al. 1999 Down; KOMARNITSKY et al. 2000 Down; SCHROEDER et al. 2000 Down). In addition, TFIIF is important for both initiation and elongation of mRNA (TAN et al. 1995 Down; FRANCOIS et al. 1998 Down). It is clear, therefore, that the multiple protein interactions possible for these proteins and protein complexes can engender many and varied roles for these factors. We report genetic evidence that the CCR4-NOT complex in addition to its known roles in transcriptional initiation has a function in transcriptional elongation.

The CCR4-NOT complex affects gene expression both positively and negatively (DENIS 1984 Down; DENIS and MALVAR 1990 Down; SAKAI et al. 1992 Down; COLLART and STRUHL 1993 Down, COLLART and STRUHL 1994 Down; LIU et al. 1998B Down). The repressive effects of the complex have been linked to restricting TBP access to noncanonical TATAA sequences (COLLART and STRUHL 1994 Down; COLLART 1996 Down), apparently through the interaction with multiple TAF proteins (BADARINARAYANA et al. 2000 Down; LEMAIRE and COLLART 2000 Down), and more recently to effects on the degradation of mRNA (TUCKER et al. 2001 Down). However, the partial nonoverlap of phenotypes observed when different components of the CCR4-NOT complex are deleted (BAI et al. 1999 Down) and the positive role for the complex in gene expression (DENIS 1984 Down; LIU et al. 1998B Down) suggest additional functions for the CCR4-NOT complex.

The CCR4-NOT complex is present in at least two forms in yeast, 1.9 x 106 daltons (1.9 MD) and 1.0 MD (LIU et al. 1997 Down, LIU et al. 1998B Down; BAI et al. 1999 Down). The smaller, core 1.0-MD complex has been well characterized and consists of CCR4, CAF1, the five NOT proteins (NOT1–5), and two new proteins, CAF40 and CAF130 (DRAPER et al. 1994 Down, DRAPER et al. 1995 Down; LIU et al. 1998B Down; BAI et al. 1999 Down; J. CHEN, Y.-C. CHIANG, J. RAPPSILBER, P. RUSSELL, M. MANN and C. L. DENIS, unpublished data). Although the 1.9-MD complex remains uncharacterized, several proteins such as DBF2, MOB1, CAF4, and CAF16 have been linked to interactions with CCR4-NOT proteins and are likely components of this larger complex (LIU et al. 1997 Down; KOMARNITSKY et al. 1998 Down; LIU et al. 2001 Down). The arrangement of the proteins in the 1.0-MD CCR4-NOT complex have been analyzed (LIU et al. 1998B Down; BAI et al. 1999 Down; MAILLET et al. 2000 Down). CCR4 and CAF1 bind to a central region of NOT1 whereas NOT2, NOT5, and NOT4 associate through the C terminus of NOT1. CAF40 and CAF130, although their locations are less clear, associate with a different part of the complex than that with which either CCR4 and CAF1 or NOT2, NOT5, and NOT4 are associated (J. CHEN, Y.-C. CHIANG, J. RAPPSILBER, P. RUSSELL, M. MANN and C. L. DENIS, unpublished data). Because NOT2 and NOT5 appear primarily responsible for TFIID interactions (BADARINARAYANA et al. 2000 Down; LEMAIRE and COLLART 2000 Down), CCR4 may be making contacts and playing roles in the cell other than that evinced by NOT2 and NOT5.

A number of factors have been shown to play possible roles in eukaryotic transcriptional elongation (CHAVEZ and AGUILERA 1997 Down; UPTAIN et al. 1997 Down; HARTZOG et al. 1998 Down; WADA et al. 1998 Down; CHAVEZ et al. 2000 Down; COSTA and ARNDT 2000 Down). In yeast defects in many of these factors affecting elongation such as SPT5, SPT4, SPT6, RTF1, RPB2, RPB1, TFIIS, and ELP1 elicit 6-azauracil (6AU) and mycophenolic sensitive phenotypes (ARCHAMBAULT et al. 1992 Down; EXINGER and LACROUTE 1992 Down; POWELL and REINES 1996 Down; HARTZOG et al. 1998 Down; LENNON et al. 1998 Down; OTERO et al. 1999 Down; COSTA and ARNDT 2000 Down). 6AU sensitivities result from lowering of GTP and/or UTP levels in the cell that is presumed to impair elongation (EXINGER and LACROUTE 1992 Down). We have observed that a deletion of CCR4 or other components of the CCR4-NOT complex gives rise to a 6AU sensitive phenotype. In confirmation of a role for CCR4 in elongation, the ccr4 deletion causes synthetic and allele-specific phenotypes with several known defects in elongation factors. Moreover, a ccr4 deletion or overexpression of NOT1 suppresses an spt5-242 defect that has been shown previously to be suppressed by the slowing of elongation. These and other results suggest a role for components of the CCR4-NOT complex in controlling transcriptional elongation.


*  MATERIALS AND METHODS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Yeast strains and growth conditions:
Yeast strains are listed in Table 1. Strains were grown on YEP plates (1% yeast extract/2% Bacto-peptone/2% agar) supplemented with either 2% glucose (YD plates) or 3% glycerol (YG plates). Minimal plates were prepared lacking uracil as described (BADARINARAYANA et al. 2000 Down) and were supplemented with 100 µg/ml 6AU, 40 µg/ml mycophenolic acid, or 600 µg/ml guanine. IMPDH assays were conducted as previously described for ADH assays (LIU et al. 1998B Down), except the reaction conditions contained 20 mM IMP, 50 mM glutathione, and 50 mM Tris, pH 7.5 instead of 0.3 M ethanol and 50 mM pyrophosphate buffer. Standard errors of the mean were <20% in all cases.


 
View this table:
In this window
In a new window

 
Table 1. Yeast strains


*  RESULTS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Defects in CCR4-NOT complex components elicit 6AU sensitive phenotypes:
It was previously observed that a ccr4 deletion could give rise to 6AU sensitivity (CHANG et al. 1999 Down). We examined this further by analyzing a number of different strains and their corresponding ccr4 derivatives for growth on medium containing 6AU. In each case, a ccr4 defect resulted in 6AU sensitivity (data not shown), indicating that 6AU sensitivity was another phenotype, like caffeine sensitivity, cold sensitivity, and glycerol 37° sensitivity, that was associated with a ccr4 disruption (DENIS and MALVAR 1990 Down; LIU et al. 1997 Down). We also examined whether defects in other components of the CCR4-NOT complex elicited 6AU sensitivity (Fig 1). In addition to ccr4, we found that caf1, not1-2, not2-1, not4, and not5 mutations each gave rise to a 6AU phenotype (Fig 1). While a not3 deletion did not result in a 6AU sensitive phenotype (Fig 1), the not3-2 allele did (data not shown). This is in agreement with previous results showing that the not3-2 allele generally results in more severe phenotypes than the not3 deletion (LIU et al. 1998B Down; our unpublished data). As 6AU sensitivity in yeast has been generally correlated with defects in transcriptional elongation, although not exclusively so, these results suggest that the CCR4-NOT complex plays a role in elongation in addition to its known role in controlling initiation (DENIS and MALVAR 1990 Down; SAKAI et al. 1992 Down; COLLART and STRUHL 1994 Down).



View larger version (64K):
In this window
In a new window
Download PPT slide
 
Figure 1. Defects in CCR4-NOT components result in 6AU sensitivity. All yeast strains were grown on minimal medium lacking uracil (-6AU) that was supplemented with 100 µg/ml 6AU (+6AU). Growth was monitored after 5 days at 34° although similar results were obtained at 30° and 25°. All strains were isogenic to either EGY188 (wt) or KY803 (whose growth was identical to EGY188). It should be noted that all strains grew well on minimal medium containing both 6AU and uracil.

6AU sensitivity appears to arise from 6AU lowering the levels of GTP and UTP in the cell (EXINGER and LACROUTE 1992 Down). Provision of excess guanine has been found to overcome 6AU sensitivity (EXINGER and LACROUTE 1992 Down). Similarly, we found that excess guanine could rescue the 6AU sensitive phenotype observed by defects in CCR4-NOT genes (data not shown). Mycophenolic acid similarly acts to decrease GTP levels in the cell and ccr4, caf1, and not4 deletions also resulted in sensitivity to mycophenolic acid (data not shown), indicating that it was not some specific interaction between 6AU and defects in the CCR4-NOT complex components that elicited the above described phenotypes. Defects in other factors known to associate with the 1.9-MD CCR4-NOT complex but which are not components of the 1-MD CCR4-NOT complex, such as CAF4, CAF16, and DBF2, did not elicit a 6AU sensitive phenotype (Fig 1; data not shown). These data indicate that it is the functionality of the core CCR4-NOT components that are important to the 6AU sensitivity phenotype.

The 6AU sensitivity observed by defects in CCR4-NOT proteins was not, however, found to occur when other known factors involved in transcriptional initiation were deleted. Deletion of PAF1 or CDC73, whose protein products have been shown to be part of an RNA polymerase II complex containing CCR4, did not elicit a 6AU phenotype (CHANG et al. 1999 Down; data not shown). Similarly, deletion of RNA polymerase II holoenzyme components, SRB5, SRB9, SRB10, SRB11, GAL11, or SIN4, or SAGA components ADA2 or GCN5 failed to result in 6AU sensitivity (data not shown).

We further examined whether defects in factors that cause a decreased rate of RNA degradation and hence a reduction in recycling of NTPs could result in a 6AU sensitivity phenotype. Defects in proteins known to be involved in mRNA degradation, such as XRN1 (MUHLRAD et al. 1995 Down), or the exosome components SKI8, SKI6, SKI2, or SKI3 (VAN HOOF et al. 2000 Down) did not result in 6AU sensitivity phenotypes (data not shown).

Disruption in CCR4-NOT function has been previously observed either by deleting specific components of the complex or by overexpressing an individual component of the complex (BADARINARAYANA et al. 2000 Down). This latter phenomenon probably results from disturbing the balance within the complex and thereby interrupting its functional contacts (BADARINARAYANA et al. 2000 Down). We consequently tested the effect of overproducing each of the components of the CCR4-NOT complex on sensitivity to 6AU. Only NOT4 overexpression resulted in poor growth on medium containing 6AU, although it had no major effect on growth on medium not containing 6AU (data not shown). These results suggest that it is the functionality and potentially the balance of components within the CCR4-NOT complex that is critical to the 6AU sensitivity phenotype.

The ccr4 mutation displays synthetic interactions with defects in the RPB2, TFIIS, and SPT16 elongation factors:
If CCR4 were to be involved in transcriptional elongation processes, defects in CCR4 might be expected to result in synergistic defects or lethalities when combined with defects in other known elongation factors. Previously we had shown that combining the ccr4 deletion with that of hprl, encoding a factor known to control elongation in yeast (CHAVEZ and AGUILERA 1997 Down; CHAVEZ et al. 2000 Down; Y. CUI and C. L. DENIS, unpublished data), results in a synthetic lethality (CHANG et al. 1999 Down). We extended these results by analyzing the effect of ccr4 in combination with defects in elongation factors RPB2, TFIIS, and SPT16 (a component of the FACT elongation complex; ORPHANIDES et al. 1999 Down).

The rpb2-10 and, to a lesser degree, the rpb2-4 allele have been shown to slow RNA polymerase II elongation in vitro (POWELL and REINES 1996 Down). They and the rpb2-7 allele (which had no effect on in vitro elongation) all result in 6AU sensitive phenotypes (POWELL and REINES 1996 Down). When ccr4 was combined with each of these three alleles, rpb2-10 ccr4- and rpb2-4 ccr4-containing strains displayed reduced growth at 30° and an inability to grow at 39°, normally a permissive temperature for ccr4 or rpb2 mutants (Fig 2). The rpb2-7 allele when combined with ccr4 did not cause reduced growth at 30°, but did exhibit a temperature-sensitive phenotype at 37°, slightly lower than that observed for ccr4 rpb2-4 or ccr4 rpb2-10 combinations (Fig 2). The temperature-sensitivity phenotypes observed when the rpb2 alleles were combined with ccr4 were found, however, to be suppressed by growth on minimal medium, suggesting that slowing growth allowed the cell to overcome the block caused by the combination of ccr4 and rpb2 defects (Fig 2). Moreover, each of the three rpb2 alleles when combined with ccr4 resulted in a failure to grow on nonfermentative carbon sources (Fig 2). This latter phenotype is not a result of permanent damage to the mitochondria since revertants capable of growing on nonfermentable carbon sources were obtained in ccr4 rpb2-10 and ccr4 rpb2-4 backgrounds (data not shown). We also observed that the rpb2-10 ccr4-containing strain was capable of growth on medium containing 6AU after 7 days whereas even after 7 days of growth the strains harboring the rpb2-4 ccr4 or rpb2-7 ccr4 alleles remained 6AU sensitive (data not shown). This latter phenomenon suggests an allele-specific interaction between loss of CCR4 function and the rpb2-10 allele.



View larger version (29K):
In this window
In a new window
Download PPT slide
 
Figure 2. Synthetic interaction between ccr4 and rpb2, dst1, and spt16 defects. Yeast strains were grown on YD, YG, or ura- plates at the temperatures indicated. wt, strain Z96 (isogenic to DY103 except it lacks the URA3 plasmid); all other strains were isogenic to DY103 except spt16 (H154) and spt16 ccr4 (H154-1a).

We extended these analyses by analyzing the effect of combining ccr4 with a deletion in DST1, the gene encoding TFIIS. As observed for the rpb2 alleles, dstl when combined with ccr4 resulted in 39° temperature sensitivity (Fig 2), a phenotype that was suppressed by growth on minimal medium (data not shown), and a nonfermentative growth defect (Fig 2). Similarly, we observed that a ccr4 deletion when combined with the spt16-197 allele gave rise to a 34° temperature-sensitive phenotype that was not observed with either ccr4 or spt16-197 alone (Fig 2). However, combining ccr4 with defects in elongation factors did not always result in severe phenotypes. No augmentation of phenotype was observed when ccr4 was combined with elp1, spt4, or the spt5 alleles, spt5-8 or spt5-242 (data not shown). These above results indicate two important points. First, combining ccr4 with mutations in RPB2, DST1, or SPT16 that are known or presumed to be defective in elongation results in more severe phenotypes. Combining ccr4 with the rpb2-3 allele that affects transcriptional initiation events (LEE et al. 1998 Down) did not result in synergistic effects (data not shown). Second, ccr4 displays an allele-specific effect with the rpb2-10 allele, suggesting a functional link between the corresponding proteins. These results support a role for CCR4 in transcript elongation.

rpb1 alleles involved in elongation display allele-specific interactions with ccr4:
Two rpb1 alleles (rpb1-221 and rpb1-244) that have been previously described cause synthetic defects with a dst1 deletion (HARTZOG et al. 1998 Down). These rpb1 alleles also suppress the cold-sensitive defect associated with the spt5-242 allele, confirming a role for these alleles in elongation processes controlled by the SPT4-SPT5 complex (HARTZOG et al. 1998 Down). We subsequently examined the effect of combining a ccr4 deletion with the rpb1-221 and rpb1-244 alleles. We found that combining a ccr4 deletion with the rpb1-244 allele resulted in a severity of phenotypes greater than that for ccr4 combined with rpb1-221 (Fig 3). Strains containing ccr4 rpb1-244 displayed weaker growth at 30° and no growth at 37° (Fig 3) and were unable to grow on nonfermentative carbon sources (data not shown). The poor viability of rpb1-244 with ccr4 is similar to that observed between rpb1-244 and a dst1 deletion (HARTZOG et al. 1998 Down). We also observed that the ccr4 rpb1-244 synthetic lethalities were completely relieved by reintroduction of a wild-type CCR4 gene into the strain. In addition, when ccr4 was combined with the rpb1-1 allele, known to affect initiation of transcription (HOLSTEGE et al. 1998 Down), no synergistic effects were obtained (data not shown).



View larger version (19K):
In this window
In a new window
Download PPT slide
 
Figure 3. Allele-specific interactions between the ccr4 and rpb1 allele. Yeast strains were grown on YD plates at the temperatures indicated. wt, strain FY1642; rpb1-244, strain GHY-149; rpb1-221, strain FY1638; ccr4 derivatives were isogenic to the above three strains.

The spt5-242 cold-sensitive allele is suppressed by ccr4 or overexpression of NOT1:
The above described rpb1-244 and rpb1-221 alleles were initially identified as suppressors of the cold-sensitive phenotype associated with spt5-242. Similarly, the rpb2-10 allele, which causes an in vitro defect for transcriptional elongation (POWELL and REINES 1996 Down), is also capable of suppressing spt5-242 (HARTZOG et al. 1998 Down). Slowing of elongation in vivo by the addition of 6AU also suppressed spt5-242. Because of the known role of human homologs of SPT5 in elongation (WADA et al. 1998 Down), it was postulated that slowing of elongation allows rescue of the spt5-242 elongation defect (HARTZOG et al. 1998 Down). We therefore tested if a ccr4 deletion or overexpression of individual CCR4-NOT complex components could also rescue the spt5-242 cold-sensitive phenotype. As summarized in Table 2, the spt5-242 cold-sensitive phenotype was capable of being suppressed by a ccr4 deletion. Also, overexpression of the NOT1 gene specifically suppressed the spt5-242 phenotype (Table 2). Overexpression of the NOT1 gene resulted in about three- to fourfold more NOT1 protein in the cell than normally was present (data not shown). These results support the model that CCR4 and the NOT proteins affect transcriptional elongation.


 
View this table:
In this window
In a new window

 
Table 2. The cold-sensitive phenotype of spt5-242 is suppressed by ccr4 and increased expression of NOT1

One simple model for the effect of ccr4 on elongation would be that components of the CCR4-NOT complex, as transcriptional regulators, affect the expression of the rate-limiting enzyme IMPDH in the synthesis of GTP (GLESNE et al. 1991 Down; SHAW and REINES 2000 Down). Decreasing GTP levels would be expected to slow elongation. Because of the existence of four separate genes encoding IMPDH (SHAW and REINES 2000 Down), we chose to quantitate the effect of CCR4-NOT defects directly on IMPDH enzyme levels in the cell. IMPDH enzyme levels (100 milliunits/mg in wild type) were found, however, to be relatively unchanged with the ccr4 (120 milliunits/mg IMPDH), not1-2 (100 milliunits/mg), not2-1 (80 milliunits/mg), or not4 (120 milliunits/mg) alleles, although a caf1 deletion did result in a twofold drop in IMPDH enzyme levels to 56 milliunits/mg.


*  DISCUSSION
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Genetic evidence for CCR4 involvement in transcriptional elongation:
We have provided genetic evidence that supports a role for CCR4 and components of the CCR4-NOT complex in regulating transcriptional elongation. This novel role for these proteins is supported by several observations. First, defects in nearly all of the individual components of the 1.0-MD core CCR4-NOT complex as well as overexpression of NOT4 elicited 6AU and mycophenolic sensitive phenotypes. These phenotypes were not generally associated with defects in other factors involved in transcriptional initiation and mRNA degradation, or with CCR4-NOT complex components (CAF4, CAF16, and DBF2) not part of the 1.0-MD CCR4-NOT complex. Second, deletion of ccr4 resulted in severe synthetic effects with defects in several known elongation factors: hprl, rpb2, rpb1, dst1, and spt16. Because the biochemical mechanism of action by several of these elongation factors remains largely unknown, it is difficult to ascertain at what step or pathway CCR4 is involved. The spectrum of synthetic defects observed with ccr4 suggests that the CCR4 protein may play a role in a novel aspect of this regulation.

Third, a ccr4 deletion displayed an allele-specific interaction with the rpb1-244 allele that has been suggested to play a role in elongation (HARTZOG et al. 1998 Down). This result suggests a functional interaction between CCR4 and RPB1 in terms of elongation and is supported by the previous observations that CCR4 is a component of the PAF1-containing RNA polymerase II transcription complex (CHANG et al. 1999 Down) and that components of the 1.9-MD CCR4-NOT complex display multiple physical interactions with the SRB9-11 proteins of the RNA polymerase II holoenzyme (LIU et al. 2001 Down). Finally, we showed that a ccr4 deletion or overexpression of NOT1 suppressed the cold-sensitive phenotype associated with the spt5-242 allele, suggesting that they slow the rate of elongation (HARTZOG et al. 1998 Down). The particular effect of NOT1 overexpression may result from its role as the scaffold for the CCR4-NOT complex and thereby affect the integrity of the complex by its overexpression (BAI et al. 1999 Down).

While the above evidence supports a direct role for CCR4-NOT proteins in affecting some aspect of elongation, it remains possible that the described interactions result from indirect effects of CCR4-NOT factors on transcription initiation processes. Although it is difficult to formally eliminate this alternative explanation, the above multiple correlations between ccr4 and elongation defects and the observation that the CCR4-NOT proteins do not significantly affect the overall enzyme levels of IMPDH in the cell makes this suggestion seem unlikely. In addition, whereas it has been suggested that the dst1 deletion causes sensitivity to 6AU due to its effect on the transcription of the SSM1 gene (SHIMOARAISO et al. 2000 Down), we have found that ccr4 has no effect on SSM1 mRNA synthesis (H. BAKER and C. L. DENIS, unpublished data).

Relationship of CCR4-NOT function in initiation to that of elongation:
The CCR4-NOT proteins have been implicated in the control of transcriptional initiation by a number of studies (DENIS and MALVAR 1990 Down; SAKAI et al. 1992 Down; COLLART and STRUHL 1994 Down). The most critical of this evidence is the enhanced transcription from the TATAA-less promoter at HIS3 (COLLART and STRUHL 1993 Down, COLLART and STRUHL 1994 Down), the suppression by ccr4 and caf1 of spt10-enhanced ADH2 expression but not of ADR1c-enhanced ADH2 expression (DENIS 1984 Down; DRAPER et al. 1995 Down), and the effect of CCR4-NOT proteins on promoters placed in front of different reporter genes (LIU et al. 1998B Down). Moreover, ccr4 does not affect the degradation rate of ADH2 mRNA or elongation through the ADH2 gene (Y. CUI and C. L. DENIS, unpublished data), indicating that the effects of ccr4 on ADH2 expression must be at the level of initiation of transcription. In addition, the CCR4-NOT proteins exhibit multiple contacts to proteins playing important roles in controlling initiation (TFIID, ADA2, and SRB9-11; BENSON et al. 1998 Down; LEE et al. 1998 Down; BADARINARAYANA et al. 2000 Down; LEMAIRE and COLLART 2000 Down; LIU et al. 2001 Down).

Yet, the multiple roles played by other initiation factors in such processes as DNA repair, promoter clearance, transcriptional elongation, polyadenylation, and 3' end formation suggests that factors controlling initiation can be utilized in other facets of DNA/RNA metabolism. In addition to the genetic evidence described herein, the CCR4-NOT proteins display several characteristics suggestive of roles in aspects of RNA formation other than that of initiation. First, CCR4 is part of the PAF1-RNA polymerase II complex (CHANG et al. 1999 Down), which contains HPR1, a protein involved in elongation rather than in initiation (CHAVEZ and AGUILERA 1997 Down; CHAVEZ et al. 2000 Down; our unpublished data). Second, CCR4-NOT components interact with the subset of proteins SRB9, -10, and -11 of the RNA polymerase II holoenzyme (LIU et al. 2001 Down). While this complex does function in initiation, the importance of SRB10 in phosphorylation of RNA polymerase II (HENGARTNER et al. 1998 Down) and the dependency of elongation on this phosphorylation (PAYNE et al. 1989 Down), suggests a critical role for SRB10 in creating a competent elongating form of RNA polymerase II. Although the SRB9, -10, and -11 proteins generally act as repressors, which has been linked to preinitiation control of RNA polymerase II, they can also function as activators (HOLSTEGE et al. 1998 Down; LIU et al. 2001 Down) and may be involved in another aspect of RNA formation. As suggested previously (AKHTAR et al. 1996 Down), activators or coactivators like the CCR4-NOT proteins could aid in setting up processive polymerases at the promoter and thereby generate more active or increased numbers of elongating polymerases.

Third, components of the CCR4-NOT complex appear to display functions linked to direct RNA/DNA contacts. CCR4 and CAF1 display sequence homology and enzymatic activities related to exo- and endonucleases (MOSER et al. 1997 Down; DLAKIC 2000 Down; TUCKER et al. 2001 Down; J. CHEN, Y.-C. CHIANG and C. L. DENIS, unpublished data) and NOT4 contains a putative RNA binding domain (ALBERT et al. 2000 Down; our unpublished data). It is, therefore, likely that these proteins are involved directly in contributing to some facet of RNA synthesis, degradation, or monitoring. Such interactions are consistent with possible roles of these proteins in several aspects of elongation.

Recently, another presumed initiation factor, RTF1, has been found to display multiple genetic interactions with elongation factors and display 6AU sensitive phenotypes (COSTA and ARNDT 2000 Down). The intrinsic overlap between initiation and elongation suggests that identifying factors like RTF1 and CCR4-NOT proteins that could act in both processes will not be unique to these factors. These proteins could act to affect promoter clearance, elongation procession, rescue of stalled complexes, or interaction with chromatin rearrangement factors. Identification of specific target genes controlled at the level of elongation by these factors would be one step toward elucidating their precise mechanisms of action.


*  ACKNOWLEDGMENTS

We thank F. Winston, A. Aguilera, and G. Hartzog for their generous provision of yeast strains used in this work. We are also indebted to D. Reines for providing strains and valuable discussions that aided this study, and to D. Reines, G. Hartzog, and K. Arndt for comments in regard to the manuscript. The secretarial skills of B. Lauze are also appreciated. This research was supported by National Institutes of Health grant GM41215. This is publication no. 2077 from the New Hampshire Agricultural Experiment Station.

Manuscript received January 5, 2001; Accepted for publication March 15, 2001.


*  LITERATURE CITED
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

AKHTAR, A., G. FAYE, and D. L. BENTLEY, 1996  Distinct activated and non-activated RNA polymerase II complexes in yeast. EMBO J. 15:4654-4664[Medline].

ALBERT, T., M. LEMAIRE, N. L. VAN BERKUM, R. GENTZ, and M. A. COLLART et al., 2000  Isolation and characterization of human orthologs of yeast CCR4-NOT complex subunits. Nucleic Acids Res. 28:809-817[Abstract/Free Full Text].

ARCHAMBAULT, J., F. LACROUTE, A. RUET, and J. D. FRIESEN, 1992  Genetic interaction between transcription elongation factor TFIIS and RNA polymerase II. Mol. Cell. Biol. 12:4142-4152[Abstract/Free Full Text].

BADARINARAYANA, V., Y.-C. CHIANG, and C. L. DENIS, 2000  Functional interaction of CCR4-NOT proteins with TATAA-Binding Protein (TBP) and its associated factors in yeast. Genetics 155:1045-1054[Abstract/Free Full Text].

BAI, Y., C. SALVADORE, Y.-C. CHIANG, M. COLLART, and H. Y. LIU et al., 1999  The CCR4 and CAF1 proteins of the CCR4-NOT complex are physically and functionally separated from NOT2, NOT4, and NOT5. Mol. Cell. Biol. 19:6642-6651[Abstract/Free Full Text].

BENSON, J. D., M. BENSON, P. M. HOWLEY, and K. STRUHL, 1998  Association of distinct yeast Not2 functional domains with components of Gcn5 histone acetylase and Ccr4 transcriptional regulatory complexes. EMBO J. 17:6714-6722[Medline].

CHANG, M., D. FRENCH-CONRNAY, H.-Y. FAN, H. KLEIN, and C. L. DENIS et al., 1999  A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling. Mol. Cell. Biol. 19:1056-1067[Abstract/Free Full Text].

CHAVEZ, S. and A. AGUILERA, 1997  The yeast HPR1 gene has a functional role in transcriptional elongation that uncovers a novel source of genome instability. Genes Dev. 2:3459-3470.

CHAVEZ, S., T. BEILHARZ, A. G. RONDON, H. ERDJUMENT-BROMAGE, and P. TEMPST et al., 2000  A protein complex containing Tho2, Hpr1, Mft1 and a novel protein, Thp2, connects transcription elongation with mitotic recombination in Saccharomyces cerevisiae.. EMBO J. 19:5824-5834[Medline].

COLLART, M. A., 1996  The NOT, SPT3, and MOT1 genes functionally interact to regulate transcription at core promoters. Mol. Cell. Biol. 16:6668-6676[Abstract].

COLLART, M. A. and K. STRUHL, 1993  CDC39, an essential nuclear protein that negatively regulates transcription and differentially affects the constitutive and inducible HIS3 promoters. EMBO J. 12:177-186. (erratum: EMBO J. 12: 2990).[Medline].

COLLART, M. A. and K. STRUHL, 1994  NOT1(CDC39), NOT2 (CDC36), NOT3, and NOT4 encode a global-negative regulator of transcription that differentially affects TATA-element utilization. Genes Dev. 8:525-537[Abstract/Free Full Text].

COSTA, P. J. and K. M. ARNDT, 2000  Synthetic lethal interactions suggest a role for the Saccharomyces cerevisiae Rtf1 protein in transcription elongation. Genetics 156:535-547[Abstract/Free Full Text].

DANTONEL, J.-C., K. G. K. MURTHY, J. L. MANLEY, and L. TORA, 1997  Transcription factor TFIID recruits factor CPSF for formation of 3' end of mRNA. Nature 389:399-402[Medline].

DENIS, C. L., 1984  Identification of new genes involved in the regulation of yeast alcohol dehydrogenase II. Genetics 108:833-844[Abstract/Free Full Text].

DENIS, C. L. and T. MALVAR, 1990  The CCR4 gene from Saccharomyces cerevisiae is required for both nonfermentative and spt-mediated gene expression. Genetics 124:283-291[Abstract].

DLAKIC, M., 2000  Functionally unrelated signaling proteins contain a fold similar to Mg2+-dependent endonucleases. Trends Biochem. Sci. 25(6):272-273[Medline].

DRAPER, M. P., H. Y. LIU, A. H. NELSBACH, S. P. MOSLEY, and C. L. DENIS, 1994  CCR4 is a glucose-regulated transcription factor whose leucine-rich repeat binds several proteins important for placing CCR4 in its proper promoter context. Mol. Cell. Biol. 14:4522-4531[Abstract/Free Full Text].

DRAPER, M. P., C. SALVADORE, and C. L. DENIS, 1995  Identification of a mouse protein whose homolog in Saccharomyces cerevisiae is a component of the CCR4 transcriptional regulatory complex. Mol. Cell. Biol. 15:3487-3495[Abstract].

DRAPKIN, R., J. T. REARDON, A. ANSARI, J.-C. HUANG, and L. ZAWEL et al., 1994  Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 368:769-772[Medline].

EXINGER, F. and F. LACROUTE, 1992  6-Azauracil inhibition of GTP biosynthesis in Saccharomyces cerevisiae.. Curr. Genet. 22:9-11[Medline].

FRANCOIS, R., M. DOUZIECH, D. FORGET, J.-M. EGLY, and J. GREENBLATT et al., 1998  Wrapping of promoter DNA around the RNA polymerase II initiation complex induced by TFIIF. Mol. Cell. 2:341-351[Medline].

GLESNE, D. A., F. R. COLART, and E. HUBERMAN, 1991  Regulation of IMP dehydrogenase gene expression by its end products, guanine nucleotides. Mol. Cell. Biol. 11:5417-5425[Abstract/Free Full Text].

GRANT, P. A., L. DUGGAN, J. CÔTÉ, S. M. ROBERTS, and J. E. BROWNELL et al., 1997  Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev. 11:1640-1650[Abstract/Free Full Text].

HARTZOG, G. A., T. WADA, H. HANDA, and F. WINSTON, 1998  Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae.. Genes Dev. 12:357-369[Abstract/Free Full Text].

HENGARTNER, C. J., V. E. MYER, S.-M. LIAO, C. J. WILSON, and S. S. KOH et al., 1998  Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell 2:43-53[Medline].

HIROSE, Y. and J. L. MANLEY, 1998  RNA polymerase II is an essential mRNA polyadenylation factor. Nature 395:93-97[Medline].

HIROSE, Y., R. TACKE, and J. L. MANLEY, 1999  Phosphorylated RNA polymerase II stimulates pre-mRNA splicing. Genes Dev. 13:1234-1239[Abstract/Free Full Text].

HOLSTEGE, F. C. P., E. G. JENNINGS, J. J. WYRICK, T. I. LEE, and D. J. HENGARTNER et al., 1998  Dissecting the regulatory circuitry of a eukaryotic genome. Cell 95:717-728[Medline].

KIM, T.-K., R. H. EBRIGHT, and D. REINBERG, 2000  Mechanism of ATP-dependent promoter melting by transcription factor IIH. Science 288:1418-1421[Abstract/Free Full Text].

KOMARNITSKY, P., E.-J. CHO, and S. BURATOWSKI, 2000  Different phosporylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14:2452-2460[Abstract/Free Full Text].

KOMARNITSKY, S., Y.-C. CHIANG, F. C. LUCA, J. CHEN, and J. TOYN et al., 1998  DBF2 protein kinase binds to and acts through the cell cycle-regulated MOB1 protein. Mol. Cell. Biol. 18:2100-2107[Abstract/Free Full Text].

LEE, T. I., J. J. WYRICK, S. S. KOH, E. G. JENNINGS, and E. L. GADBOIS et al., 1998  Interplay of positive and negative regulators in transcription initiation by RNA polymerase II holoenzyme. Mol. Cell. Biol. 18:4455-4662[Abstract/Free Full Text].

LEMAIRE, M. and M. A. COLLART, 2000  The TATA-binding protein-associated factor yTAFII19p functionally interacts with components of the global transcriptional regulator CCR4-NOT complex and physically interacts with the Not5 subunit. J. Biol. Chem. 275:26925-26934[Abstract/Free Full Text].

LENNON, J. C., III, M. WIND, L. SAUNDERS, M. B. HOCK, and D. REINES, 1998  Mutations in RNA polymerase II and elongation factor SII severely reduce mRNA levels in Saccharomyces cerevisiae.. Mol. Cell. Biol. 18:5771-5779[Abstract/Free Full Text].

LIU, D., R. ISHIMA, K. I. TONG, S. BAGBY, and T. KOKUBO et al., 1998a  Solution structure of a TBP-TAFII230 complex: protein mimicry of the minor groove surface of the TATA box unwound by TBP. Cell 94:573-583[Medline].

LIU, H.-Y., V. BADARINARAYANA, D. AUDINO, J. RAPPSILBER, and M. MANN et al., 1998b  The NOT proteins are part of the CCR4 transcriptional complex and affect gene expression both positively and negatively. EMBO J. 17:1096-1106[Medline].

LIU, H.-Y., J. H. TOYN, Y.-C. CHIANG, M. P. DRAPER, and L. H. JOHNSTON et al., 1997  DBF2, a cell cycle-regulated protein kinase, is physically and functionally associated with the CCR4 transcriptional regulatory complex. EMBO J. 16:5289-5298[Medline].

LIU, H.-Y., Y.-C. CHIANG, J. PAN, J. CHEN, and C. SALVADORE et al., 2001  Characterization of CAF4 and CAF16 reveal a functional connection between the CCR4-NOT complex and a subset of SRB proteins of the RNA polymerase II holoenzyme. J. Biol. Chem. 276:7541-7548[Abstract/Free Full Text].

MAILLET, L., C. TU, Y.-K. HONG, E. O. SHUSTER, and M. A. COLLART, 2000  The essential function of Not1 lies within the Ccr4-Not complex. J. Mol. Biol. 303:131-143[Medline].

MCCRACKEN, S., N. FONG, E. ROSONINA, K. YANKULOV, and G. BROTHER et al., 1997  5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev. 11:3306-3318[Abstract/Free Full Text].

MIZZEN, C. A., X.-J. YANG, T. KOKUBO, J. E. BROWNELL, and A. J. BANNISTER et al., 1996  The TAFII250 subunit of TFIID has histone acetyltransferase activity. Cell 87:1261-1270[Medline].

MOSER, M. J., W. R. HOLLEY, A. CHATTERJEE, and I. S. MIAN, 1997  The proofreading domain of Escherichia coli DNA polymerase I and other DNA and/or RNA exonuclease domains. Nucleic Acids Res. 25:5110-5118[Abstract/Free Full Text].

MUHLRAD, D., C. J. DECKER, and R. PARKER, 1995  Turnover mechanisms of the stable yeast PGK1 mRNA. Mol. Cell. Biol. 15:2145-2156[Abstract].

ORPHANIDES, G., W.-H. WU, W. S. LANE, M. HAMPSEY, and D. REINBERG, 1999  The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature 400:284-288[Medline].

OTERO, G., J. FELLOWS, Y. LI, T. DE BIZEMONT, A. M. G. DIRAC, and C. M. GUSTAFSSON et al., 1999  Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol. Cell 3:109-118[Medline].

PAYNE, J. M., P. J. LAYBOURN, and M. E. DAHMUS, 1989  The transition of RNA polymerase II from initiation to elongation is associated with phosphorylation of the carboxyl-terminal domain of subunit IIa. J. Biol. Chem. 264:19621-19629[Abstract/Free Full Text].

PHAM, A.-D. and F. SAUER, 2000  Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila.. Science 289:2357-2360[Abstract/Free Full Text].

POWELL, W. and D. REINES, 1996  Mutations in the second largest subunit of RNA polymerase II cause 6-azauracil sensitivity in yeast and increased transcriptional arrest in vitro. J. Biol. Chem. 271:6866-6873[Abstract/Free Full Text].

SAKAI, A., T. CHIBAZAKURA, Y. SHIMIZU, and F. HISHINUMA, 1992  Molecular analysis of POP2 gene, a gene required for glucose-derepression of gene expression in Saccharomyces cerevisiae.. Nucleic Acids Res. 20:6227-6233[Abstract/Free Full Text].

SCHROEDER, S. C., B. SCHWER, S. SHUMAN, and D. BENTLEY, 2000  Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 14:2435-2440[Abstract/Free Full Text].

SHAW, R. J. and D. REINES, 2000  Saccharomyces cerevisiae transcription elongation mutants are defective in PUR5 induction in reponse to nucleotide depletion. Mol. Cell. Biol. 20:7427-7437[Abstract/Free Full Text].

SHIMOARAISO, M., N. TOSHIYUKI, T. KUBO, and S. NATORI, 2000  Transcription elongation factor S-II confers yeast resistance to 6-Azauracil by enhancing expression of the SSM1 gene. J. Biol. Chem. 275:29623-29627[Abstract/Free Full Text].

STERNER, D. E., P. A. GRANT, S. M. ROBERTS, L. J. DUGGAN, and R. BELOTSERKOVSKAYA et al., 1999  Functional organization of the yeast SAGA complex: distinct components involved in structural integrity, nucleosome acetylation, and TATA- binding protein interaction. Mol. Cell Biol. 19:86-98[Abstract/Free Full Text].

TAN, S., R. C. CONAWAY, and J. W. CONAWAY, 1995  Dissection of transcription factor TFIIF functional domains required for initiation and elongation. Proc. Natl. Acad. Sci. USA 92:6042-6046[Abstract/Free Full Text].

TUCKER, M., M. A. VALENCIA-SANCHEZ, R. STAPLES, J. CHEN, and C. L. DENIS et al., 2001  The transcription factor associated proteins Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell. 104:377-386[Medline].

UPTAIN, S. M., C. M. KANE, and M. J. CHAMBERLIN, 1997  Basic mechanisms of transcript elongation and its regulation. Annu. Rev. Biochem. 66:117-172[Medline].

VAN HOOF, A., P. LENNERTZ, and R. PARKER, 2000  Yeast exosome mutants accumulate 3'-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol. Cell. Biol. 20:441-452[Abstract/Free Full Text].

WADA, T., T. TAKAGI, Y. YAMAGUGUHI, A. FERDOUS, and T. IMAI et al., 1998  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12:343-356[Abstract/Free Full Text].




This article has been cited by other articles:


Home page
Eukaryot CellHome page
P. A. Gibney, T. Fries, S. M. Bailer, and K. A. Morano
Rtr1 Is the Saccharomyces cerevisiae Homolog of a Novel Family of RNA Polymerase II-Binding Proteins
Eukaryot. Cell, June 1, 2008; 7(6): 938 - 948.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
J. Verma-Gaur, S. N. Rao, T. Taya, and P. Sadhale
Genomewide Recruitment Analysis of Rpb4, a Subunit of Polymerase II in Saccharomyces cerevisiae, Reveals Its Involvement in Transcription Elongation
Eukaryot. Cell, June 1, 2008; 7(6): 1009 - 1018.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
K. W. Mulder, A. Inagaki, E. Cameroni, F. Mousson, G. S. Winkler, C. De Virgilio, M. A. Collart, and H. Th. M. Timmers
Modulation of Ubc4p/Ubc5p-Mediated Stress Responses by the RING-Finger-Dependent Ubiquitin-Protein Ligase Not4p in Saccharomyces cerevisiae
Genetics, May 1, 2007; 176(1): 181 - 192.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. W. Mulder, A. B. Brenkman, A. Inagaki, N. J. F. van den Broek, and H. Th. Marc Timmers
Regulation of histone H3K4 tri-methylation and PAF complex recruitment by the Ccr4-Not complex
Nucleic Acids Res., April 1, 2007; 35(7): 2428 - 2439.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
R. G. Garces, W. Gillon, and E. F. Pai
Atomic model of human Rcd-1 reveals an armadillo-like-repeat protein with in vitro nucleic acid binding properties
Protein Sci., February 1, 2007; 16(2): 176 - 188.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. W. Mulder, G. S. Winkler, and H. Th. M. Timmers
DNA damage and replication stress induced transcription of RNR genes is dependent on the Ccr4-Not complex
Nucleic Acids Res., November 7, 2005; 33(19): 6384 - 6392.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
E. Milgrom, R. W. West Jr., C. Gao, and W.-C. W. Shen
TFIID and Spt-Ada-Gcn5-Acetyltransferase Functions Probed by Genome-wide Synthetic Genetic Array Analysis Using a Saccharomyces cerevisiae taf9-ts Allele
Genetics, November 1, 2005; 171(3): 959 - 973.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. Mazzoni, A. Serafini, and C. Falcone
The Inactivation of KlNOT4, a Kluyveromyces lactis Gene Encoding a Component of the CCR4-NOT Complex, Reveals New Regulatory Functions
Genetics, July 1, 2005; 170(3): 1023 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Kaplan, M. J. Holland, and F. Winston
Interaction between Transcription Elongation Factors and mRNA 3'-End Formation at the Saccharomyces cerevisiae GAL10-GAL7 Locus
J. Biol. Chem., January 14, 2005; 280(2): 913 - 922.
[Abstract] [Full Text] [PDF]